Brett Clements
About Brett Clements
Brett Clements serves as the Executive Director—West for National Cell Therapy at Kite Pharma, a position he has held since 2020. He has a strong background in the biopharmaceutical industry, with previous roles at Clovis Oncology, Gilead Sciences, Amgen, and Pfizer.
Current Role at Kite Pharma
Brett Clements serves as the Executive Director—West for National Cell Therapy at Kite Pharma. He has held this position since 2020, contributing to the company's focus on innovative cell therapies. His role involves overseeing operations and strategic initiatives within the western region, ensuring the effective delivery of cell therapy solutions.
Previous Experience in Cell Therapy
Before his current position, Brett Clements worked at Gilead Sciences as the Kite/Gilead Senior Regional Director—Cell Therapy from 2016 to 2020. In this role, he managed operations in the South Central Region, focusing on the promotion and distribution of cell therapy products. He also briefly served as Senior Regional Director—Cell Therapy at Kite Pharma in 2020.
Career Background in Oncology
Brett Clements has extensive experience in the oncology sector. He worked at Amgen as an Oncology Sr. District Manager from 2008 to 2015, where he managed operations in the Gulf Coast region. Prior to that, he was a District Manager at Pfizer from 1992 to 2008, accumulating 16 years of experience in sales and management within the pharmaceutical industry.
Educational Background
Brett Clements earned a Master of Business Administration (MBA) in Finance and Financial Management Services from Texas A&M University, studying from 1990 to 1992. He also holds a Bachelor of Science (BS) in Biochemistry from the same institution, which he completed from 1986 to 1990. His educational background supports his expertise in both business management and the scientific aspects of cell therapy.